Mitchell Simon J
Editor, Diving and Hyperbaric Medicine Journal.
Department of Anesthesiology, University of Auckland. Private Bag 92019, Auckland 1142, New Zealand,
Diving Hyperb Med. 2019 Sep 30;49(3):152-153. doi: 10.28920/dhm49.3.152-153.
There are few issues that generate as much confusion in diving medicine as the nomenclature of bubble-induced dysbaric disease. Prior to the late 1980s, the diagnosis 'decompression sickness' (DCS) was invoked for symptoms presumed to arise as a consequence of bubble formation from dissolved inert gas during or after decompression. These bubbles were known to form within tissues, and also to appear in the venous blood (presumably after forming in tissue capillaries). A second diagnosis, 'arterial gas embolism' (AGE) was invoked for symptoms presumed to arise when bubbles were introduced directly to the arterial circulation as a consequence of pulmonary barotrauma. This approach was predicated on an assumption that the underlying pathophysiology could usually be inferred from the nature and tempo of resulting symptoms. DCS was considered to exhibit a slower more progressive onset, symptoms were protean (including pain, rash, paraesthesias, subcutaneous swelling, and neurological symptoms), and the neurological manifestations were mainly attributable to spinal cord or inner ear involvement. In contrast, AGE was considered to exhibit a more precipitous onset (often immediately on surfacing), and the principal manifestation was stroke-like focal neurological impairment suggestive of cerebral involvement. In 1989 an association between a large persistent ('patent') foramen ovale (PFO) and serious neurological DCS was independently reported by two groups, and subsequently corroborated for neurological, inner ear, and cutaneous DCS by multiple studies. The assumed pathophysiological role of a PFO in this setting was to allow bubbles formed from inert gas in the venous blood to avoid removal in the pulmonary circulation and to enter the arterial circulation. These bubbles could then pass to the microcirculation of vulnerable target tissues where inward diffusion of supersaturated inert gas from the surrounding tissue could cause them to grow. This emergence of 'arterialisation' of venous bubbles as an important vector of harm in some forms of DCS resulted in a challenge to the use of traditional 'DCS/AGE' terminology. It was suggested that very early onset of cerebral symptoms after diving could be explained not only by arterial bubbles introduced by pulmonary barotrauma, but also by venous bubbles crossing a PFO into the arterial circulation. Moreover, once venous bubbles had entered the arterial circulation they were then technically 'arterial gas emboli'; thus creating confusion with arterial gas emboli from pulmonary barotrauma. To many commentators, it made little sense to use diagnostic labels (DCS and AGE) that implied a particular pathophysiology when the two disorders might be difficult to tell apart, and had mechanistic processes in common. An alternative approach derived at a UHMS workshop in 1991 was to shift from nomenclature that implied a particular pathophysiology, to a descriptive system that lumped both DCS and AGE together under the label "decompression illness" (DCI). Using this system, terms to describe the organ system(s) involved and the progression of symptoms were applied. For example, a diver with worsening upper arm pain after a dive could be suffering 'progressive musculoskeletal DCI'; and a diver who lost consciousness immediately on surfacing but regained consciousness minutes later would be considered to be suffering 'remitting cerebral DCI'. Classifying cases in this manner made considerable sense at a clinical level, particularly given that there was an emerging consensus that manifestations of DCS and AGE that potentially overlapped did not require different approaches to recompression treatment. This descriptive classification of bubble-induced dysbaric disease gained substantial traction in the community, though not always with a full appreciation by users of the intended nuances of its application. Indeed, it became increasingly common over time to see the terms DCS and DCI used interchangeably; for example, authors using the term DCI to specifically infer the consequences of bubble formation from dissolved gas. This highlights one of the shortcomings of the DCI terminology: it becomes confusing when discussing dysbaric disease at a theoretical or experimental level when the nature of the insult is known or there is a specific intent to discuss bubble formation either from dissolved gas or from pulmonary barotrauma. The potential for confusion between mechanisms and manifestations of DCS and AGE as one of the principle drivers for adopting the DCI terminology deserves further discussion. It is tempting to suggest that if venous bubbles cross a PFO into the arterial blood then any resulting symptoms should be considered a manifestation of 'AGE'. However, there seems little sense in re-naming the primary pathophysiological event (DCS caused by bubble formation from inert gas) just because the bubbles have distributed elsewhere; especially using a name that commonly infers a completely different primary event (bubble formation from pulmonary barotrauma). Moreover, there are grounds for suggesting that these two processes may not be as difficult to distinguish as previously believed. Venous inert gas bubbles are small, and of a similar size distribution to those used as bubble contrast during PFO testing. Decades of experience in testing thousands of divers (and other patients) for PFO using bubble-contrast echocardiograpy have shown that even when strongly positive (that is, large showers of bubbles enter the arterial circulation), symptoms of any sort are very rare. There are sporadic reports of evanescent visual or cerebral symptoms, but (to this author's knowledge) reports of the focal or multifocal cerebral infarctions that can be caused by large arterial bubbles introduced iatrogenically or by pulmonary barotrauma are lacking. One could argue that in the context of PFO testing the brain is not supersaturated with inert gas (which might cause small arterial bubbles to grow), but being such a 'fast tissue' nor is it likely to be after diving. Thus, while sustained showers of small inert gas bubbles crossing a PFO after diving appeal as a plausible cause of transient visual symptoms or dysexecutive syndromes after diving, they are less likely to be the cause of dramatic stroke-like events occurring early after surfacing. In the final edition of Bennett and Elliott it was suggested that one editorial approach to the terminology conundrum would be to utilise the traditional terminology (DCS and AGE) when referring specifically to the pathophysiology and manifestations of bubble formation from dissolved inert gas or pulmonary barotrauma respectively, and to utilise the descriptive (DCI) terminology in clinical discussions when a collective term is useful, or when discussing individual patients where there is either ambiguity about pathophysiology or no need to attempt a distinction. Diving and Hyperbaric Medicine recommends a similar approach. The journal is reluctant to attempt to generate or apply hard 'rules' in relation to terminology of bubble-induced dysbaric disease, but we strongly discourage use of the term 'arterial gas emboli(ism)' to characterise venous inert gas bubbles that cross a right-to-left shunt such as a PFO. The pathophysiological consequences of bubble formation from dissolved inert gas should be regarded as decompression sickness (DCS). There is an expectation that authors are cognisant of the above issues and attempt to adopt terminology that reflects these considerations and best suits the circumstances of their manuscript.
在潜水医学领域,很少有问题能像气泡所致减压病的命名那样引发如此多的困惑。在20世纪80年代末之前,对于那些被认为是在减压过程中或减压后因溶解的惰性气体形成气泡而产生的症状,诊断为“减压病”(DCS)。已知这些气泡会在组织内形成,也会出现在静脉血中(大概是在组织毛细血管中形成后)。对于因肺气压伤导致气泡直接进入动脉循环而产生的症状,诊断为“动脉气体栓塞”(AGE)。这种方法基于这样一种假设,即潜在的病理生理学通常可以从所产生症状的性质和发展速度推断出来。DCS被认为起病较慢且呈进行性,症状多样(包括疼痛、皮疹、感觉异常、皮下肿胀和神经症状),神经表现主要归因于脊髓或内耳受累。相比之下,AGE被认为起病更急(通常在浮出水面时立即出现),主要表现为类似中风的局灶性神经功能损害,提示脑部受累。1989年,两个研究小组独立报告了大型持续性(“开放型”)卵圆孔未闭(PFO)与严重神经型DCS之间的关联,随后多项研究证实了其与神经型、内耳型和皮肤型DCS的相关性。在这种情况下,PFO假定的病理生理作用是使静脉血中由惰性气体形成的气泡避免在肺循环中被清除,并进入动脉循环。然后这些气泡可以进入易损靶组织的微循环,周围组织中超饱和惰性气体的向内扩散会导致它们增大。静脉气泡的这种“动脉化”作为某些形式DCS中一种重要的危害载体的出现,对传统的“DCS/AGE”术语的使用提出了挑战。有人认为,潜水后脑部症状的极早期发作不仅可以用肺气压伤引入动脉的气泡来解释,也可以用通过PFO进入动脉循环的静脉气泡来解释。此外,一旦静脉气泡进入动脉循环,从技术上讲它们就成了“动脉气体栓子”;因此与肺气压伤导致的动脉气体栓塞产生了混淆。对于许多评论者来说,当这两种疾病可能难以区分且有共同的机制过程时,使用暗示特定病理生理学的诊断标签(DCS和AGE)没有什么意义。1991年在水下和高压医学学会(UHMS)研讨会上得出的一种替代方法是,从暗示特定病理生理学的命名法转向一种描述性系统,该系统将DCS和AGE都归在“减压病”(DCI)这一标签下。使用这个系统时,应用描述所涉及的器官系统和症状进展的术语。例如,一名潜水员潜水后上臂疼痛加重,可能患有“进行性肌肉骨骼减压病”;一名潜水员浮出水面时立即失去意识,但几分钟后恢复意识,将被认为患有“缓解性脑减压病”。在临床层面,以这种方式对病例进行分类很有意义,特别是考虑到对于DCS和AGE可能重叠的表现,人们逐渐达成共识,即不需要采用不同的再加压治疗方法。这种对气泡所致减压病的描述性分类在该领域获得了广泛认可,尽管使用者并不总是完全理解其应用的细微差别。实际上,随着时间的推移,DCS和DCI这两个术语互换使用的情况越来越普遍;例如,作者使用DCI这个术语来专门推断溶解气体形成气泡的后果。这凸显了DCI术语的一个缺点:当在理论或实验层面讨论减压病,且已知损伤的性质或有特定意图讨论溶解气体形成气泡或肺气压伤形成气泡时,它会变得令人困惑。DCS和AGE的机制与表现之间的混淆可能性,作为采用DCI术语的主要驱动因素之一,值得进一步讨论。有人可能会认为,如果静脉气泡通过PFO进入动脉血,那么由此产生的任何症状都应被视为“AGE”的表现。然而,仅仅因为气泡分布到了其他地方就重新命名主要的病理生理事件(由惰性气体形成气泡导致的DCS)似乎没有什么意义;尤其是使用一个通常暗示完全不同的主要事件(由肺气压伤形成气泡)的名称。此外,有理由认为这两个过程可能不像以前认为的那样难以区分。静脉惰性气体气泡很小,其大小分布与PFO检测期间用作气泡造影剂的气泡相似。几十年来,使用气泡造影超声心动图对数千名潜水员(和其他患者)进行PFO检测的经验表明,即使检测结果呈强阳性(即大量气泡进入动脉循环),出现任何症状的情况都非常罕见。有零星的关于短暂视觉或脑部症状的报告,但(据作者所知)缺乏关于医源性引入或肺气压伤导致的大动脉气泡可引起的局灶性或多灶性脑梗死的报告。有人可能会争辩说,在PFO检测的背景下,大脑中惰性气体不饱和(这可能导致小动脉气泡增大),但作为一个“快速组织”,潜水后也不太可能是这样。因此,虽然潜水后持续有小惰性气体气泡通过PFO进入动脉循环似乎是潜水后短暂视觉症状或执行功能障碍综合征的一个合理原因,但它们不太可能是浮出水面后早期发生的类似中风的剧烈事件的原因。在《贝内特和埃利奥特》的最后一版中,有人建议解决术语难题的一种编辑方法是,在分别具体提及由溶解的惰性气体形成气泡或肺气压伤形成气泡的病理生理学和表现时,使用传统术语(DCS和AGE),而在临床讨论中,当需要一个统称,或者在讨论个体患者时,如果病理生理学不明确或无需区分时,使用描述性(DCI)术语。《潜水与高压医学》推荐类似的方法。该杂志不愿试图就气泡所致减压病的术语制定或应用严格的“规则”,但我们强烈不鼓励使用“动脉气体栓塞(症)”这个术语来描述通过右向左分流(如PFO)的静脉惰性气体气泡。由溶解的惰性气体形成气泡的病理生理后果应被视为减压病(DCS)。期望作者了解上述问题,并尝试采用反映这些考虑因素且最适合其稿件情况的术语。